Tada M - Search Results

1

Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.

Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H. Tada M, et al. Mol Carcinog. 1997 Mar;18(3):171-6. Mol Carcinog. 1997. PMID: 9115587

2

Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.

Tada M, Iggo RD, Ishii N, Shinohe Y, Sakuma S, Estreicher A, Sawamura Y, Abe H. Tada M, et al. Int J Cancer. 1996 Jul 29;67(3):447-50. doi: 10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3. Int J Cancer. 1996. PMID: 8707423

3

Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.

Tada M, Sawamura Y, Abe H, Iggo R. Tada M, et al. Neurosurgery. 1997 Feb;40(2):393-6. doi: 10.1097/00006123-199702000-00034. Neurosurgery. 1997. PMID: 9007876

4

Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide.

Murata J, Tada M, Iggo RD, Sawamura Y, Shinohe Y, Abe H. Murata J, et al. Among authors: tada m. Mutat Res. 1997 Oct 6;379(2):211-8. doi: 10.1016/s0027-5107(97)00149-8. Mutat Res. 1997. PMID: 9357550

5

Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.

Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y, Abe H. Matsumoto R, et al. Among authors: tada m. Cancer Res. 1998 Feb 15;58(4):609-13. Cancer Res. 1998. PMID: 9485008

6

Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay.

Nozaki M, Tada M, Matsumoto R, Sawamura Y, Abe H, Iggo RD. Nozaki M, et al. Among authors: tada m. Acta Neuropathol. 1998 Mar;95(3):291-6. doi: 10.1007/s004010050800. Acta Neuropathol. 1998. PMID: 9542595 Review.

7

Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.

Tada M, Matsumoto R, Iggo RD, Onimaru R, Shirato H, Sawamura Y, Shinohe Y. Tada M, et al. Cancer Res. 1998 May 1;58(9):1793-7. Cancer Res. 1998. PMID: 9581814

8

Monitoring adenoviral p53 transduction efficiency by yeast functional assay.

Tada M, Sakuma S, Iggo RD, Saya H, Sawamura Y, Fujiwara T, Roth JA. Tada M, et al. Gene Ther. 1998 Mar;5(3):339-44. doi: 10.1038/sj.gt.3300605. Gene Ther. 1998. PMID: 9614553

9

Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants.

Tada M, Furuuchi K, Kaneda M, Matsumoto J, Takahashi M, Hirai A, Mitsumoto Y, Iggo RD, Moriuchi T. Tada M, et al. Carcinogenesis. 2001 Mar;22(3):515-7. doi: 10.1093/carcin/22.3.515. Carcinogenesis. 2001. PMID: 11238194

10

Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.

Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG. Nozaki M, et al. Among authors: tada m. Neuro Oncol. 1999 Apr;1(2):124-37. doi: 10.1093/neuonc/1.2.124. Neuro Oncol. 1999. PMID: 11550308 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,947 results

Search Page

Filters